Disease Info Card

Stage Iv Skin Melanoma

Information about Stage Iv Skin Melanoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Stage Iv Skin Melanoma

Most recent studies have shown that Stage Iv Skin Melanoma shares some biological mechanisms with brain-neoplasms, cutaneous-melanoma, delayed-hypersensitivity, eye-neoplasms, liver-neoplasms, lung-neoplasms, lymphatic-metastasis, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanoma, metastatic-malignant-melanoma, metastatic-malignant-neoplasm-to-brain, metastatic-melanoma, nausea, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, retinal-diseases, skin-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Stage Iv Skin Melanoma, and have been seen in publications frequently: Angiogenesis, Bioluminescence, Cell Activation, Cell Adhesion, Cell Cycle, Cell Death, Cell Migration, Cytokine Production, Dna Repair, Drug Resistance, Enucleation, Excretion, Humoral Immune Response, Hypersensitivity, Immune Response, Melanocyte Differentiation, Methylation, Pathogenesis, Programmed Cell Death, Secretion

Quite a number of genes have been found to play important roles in Stage Iv Skin Melanoma, such as BRAF, CD8A, CSF2, CTLA4, DCX, HLA-A, HLA-DQA1, IFNA1, IFNG, IL2, IL4, MAGEA3, MID1, MLANA, NOD2, PMEL, TNF, TYR. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.